Recruiting NA Burn Scar

New treatment option for Burn Scar

Official title Scar Mobilization Improves Scars and Quality of Life in Burned Children.

ClinicalTrials.gov ID: NCT07578883

What this study is testing

What it's testing
This quasi-experimental study evaluates the effect of scar tissue mobilization on scar thickness, pliability, and quality of life in children with upper extremity burns. Conducted at Mayo Hospital Lahore, children aged 8-13 will receive treatment for 5 weeks, with outcomes analyzed using SPSS 27.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 8 to 13

You may be able to join if

  • 8-13 years
  • Stable scar and referred for scar management
  • Affected upper extremity joints (shoulder, elbow and wrist) with burned injuries
  • Partial thickness and full thickness burn.

You likely can't join if

  • Pre-existing skin condition or allergies
  • Neurological disorders affecting motor function
  • Fracture with burn in upper limbs
  • Patient with only superficial burns

The study team makes the final eligibility decision.

Where it's taking place

  • Lahore, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 8 years to 13 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.